Howard G. Welgus sold $114K of ARQT stock

Howard G. Welgus, Dir of Arcutis Biotherapeutics, Inc. (ARQT), sold 4,730 shares of ARQT stock worth $114K, per an SEC Form 4 filed Sep 17, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 15, 2026, 2 days before it was made public.

ARQT has moved +8.7% since the trade date, from $23.51 to $25.55 (Nov 6, 2026 close).